Naltrexone treatment
Pro Research Analysisby 
Searched over 200M research papers for "naltrexone treatment"
Naltrexone Treatment: Efficacy and Applications
Naltrexone for Alcohol Dependence
Efficacy in Chronic, Severe Alcohol Dependence
Naltrexone, an opiate-receptor antagonist, has been studied extensively for its efficacy in treating alcohol dependence. A multicenter, double-blind, placebo-controlled study involving 627 veterans with chronic, severe alcohol dependence found no significant difference in relapse rates or drinking days between those treated with naltrexone and those given a placebo over a 12-month period . This suggests that naltrexone may not be effective for individuals with severe alcohol dependence.
Combination with Cognitive Behavioral Therapy
In contrast, another study demonstrated that naltrexone, when combined with cognitive behavioral therapy (CBT), significantly improved outcomes for alcohol-dependent outpatients. Participants treated with naltrexone and CBT drank less, took longer to relapse, and had more control over alcohol-related urges compared to those receiving a placebo . This indicates that naltrexone may be more effective when used alongside structured psychosocial therapies.
Extended-Release Formulations
Extended-release injectable naltrexone (XR-naltrexone) has shown promise in improving adherence and reducing alcohol use. A multicenter trial found that XR-naltrexone led to fewer drinking days and a higher abstinence rate compared to placebo, although some results did not reach statistical significance . This suggests that long-acting formulations may enhance the effectiveness of naltrexone by ensuring consistent medication levels.
Special Populations: Older Adults and Women
For older adults, naltrexone was found to be well-tolerated and effective in preventing relapse after alcohol exposure, although it did not significantly differ from placebo in overall abstinence rates . In women, naltrexone combined with Cognitive Behavioral Coping Skills Therapy (CBCST) did not significantly improve primary drinking outcomes but did delay subsequent drinking days among those who did not maintain abstinence . These findings highlight the potential benefits of naltrexone in specific subgroups of alcohol-dependent individuals.
Naltrexone for Opioid Use Disorder
Oral vs. Extended-Release Naltrexone
Naltrexone has also been studied for opioid use disorder. An open-label trial comparing oral naltrexone to XR-naltrexone found that patients receiving the extended-release formulation had significantly higher treatment retention rates over six months . This supports the use of XR-naltrexone in improving adherence and reducing opioid use.
Broader Applications of Naltrexone
Pan-Addiction Treatment
Naltrexone's efficacy extends beyond alcohol and opioid dependence. A review of 39 studies found that naltrexone is effective across various substance use disorders, including nicotine and stimulant use, as well as behavioral addictions like gambling and kleptomania . This broad efficacy suggests a shared role of brain opioid pathways in different types of addiction.
Amphetamine Dependence
A randomized, placebo-controlled trial demonstrated that naltrexone significantly reduced amphetamine use and cravings in amphetamine-dependent individuals . This indicates that naltrexone could be a viable treatment option for amphetamine dependence, a condition with limited pharmacotherapy options.
Conclusion
Naltrexone shows varying degrees of efficacy across different types of substance use disorders and populations. While it may not be effective for severe alcohol dependence on its own, its combination with psychosocial therapies like CBT can enhance outcomes. Extended-release formulations improve adherence and treatment retention, particularly in opioid use disorder. Additionally, naltrexone's broad efficacy across various addictions underscores its potential as a versatile treatment option. Further research is warranted to optimize its use and explore its benefits in combination with other therapies.
Sources and full results
Most relevant research papers on this topic
A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder
XR-naltrexone combined with behavioral therapy is more effective for opioid withdrawal and preventing relapse compared to oral naltrexone.
Naltrexone as an adjunctive treatment for older patients with alcohol dependence.
Naltrexone is a well-tolerated and effective adjunctive treatment for alcohol dependence in older adults, preventing relapse in those who drink.
DOI